CN118632842A - 两性离子抗细菌化合物 - Google Patents
两性离子抗细菌化合物 Download PDFInfo
- Publication number
- CN118632842A CN118632842A CN202380018177.1A CN202380018177A CN118632842A CN 118632842 A CN118632842 A CN 118632842A CN 202380018177 A CN202380018177 A CN 202380018177A CN 118632842 A CN118632842 A CN 118632842A
- Authority
- CN
- China
- Prior art keywords
- carbonyl
- amino
- methyl
- pyrazol
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22158739.7 | 2022-02-25 | ||
| EP22158739 | 2022-02-25 | ||
| PCT/EP2023/054499 WO2023161316A1 (en) | 2022-02-25 | 2023-02-23 | Zwitterionic antibacterial compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118632842A true CN118632842A (zh) | 2024-09-10 |
Family
ID=80461664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380018177.1A Pending CN118632842A (zh) | 2022-02-25 | 2023-02-23 | 两性离子抗细菌化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250179066A1 (https=) |
| EP (1) | EP4482583B1 (https=) |
| JP (1) | JP2025508473A (https=) |
| CN (1) | CN118632842A (https=) |
| AR (1) | AR128612A1 (https=) |
| TW (1) | TW202402748A (https=) |
| WO (1) | WO2023161316A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016347456B2 (en) | 2015-10-27 | 2018-12-13 | F. Hoffmann-La Roche Ag | Peptide macrocycles against acinetobacter baumannii |
| US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
| WO2020182648A1 (en) | 2019-03-08 | 2020-09-17 | F. Hoffmann-La Roche Ag | Novel imidazole-pyrazole derivatives |
| CN114981259B (zh) * | 2020-01-22 | 2024-06-18 | 豪夫迈·罗氏有限公司 | 新型杂环化合物 |
-
2023
- 2023-02-23 JP JP2024550248A patent/JP2025508473A/ja active Pending
- 2023-02-23 WO PCT/EP2023/054499 patent/WO2023161316A1/en not_active Ceased
- 2023-02-23 US US18/840,608 patent/US20250179066A1/en active Pending
- 2023-02-23 EP EP23707330.9A patent/EP4482583B1/en active Active
- 2023-02-23 CN CN202380018177.1A patent/CN118632842A/zh active Pending
- 2023-02-24 TW TW112107104A patent/TW202402748A/zh unknown
- 2023-02-24 AR ARP230100452A patent/AR128612A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023161316A1 (en) | 2023-08-31 |
| TW202402748A (zh) | 2024-01-16 |
| AR128612A1 (es) | 2024-05-29 |
| US20250179066A1 (en) | 2025-06-05 |
| JP2025508473A (ja) | 2025-03-26 |
| EP4482583A1 (en) | 2025-01-01 |
| EP4482583B1 (en) | 2026-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7715634B2 (ja) | 新規イミダゾール－ピラゾール誘導体 | |
| CN104379575B (zh) | 用于调节egfr活性的化合物和组合物 | |
| JP7669372B2 (ja) | 新規な化合物及びその使用 | |
| TW201833102A (zh) | 作為ehmt2抑制劑之胺取代的雜環化合物及其使用方法 | |
| US20260062416A1 (en) | Inhibitors of kif18a and uses thereof | |
| ES2907858T3 (es) | Compuestos y métodos para el tratamiento de infecciones bacterianas | |
| AU2018334272A1 (en) | Tetrahydro-imidazo quinoline compositions as CBP/p300 inhibitors | |
| JP2024534169A (ja) | Ｅｇｆｒ阻害剤としての置換アミノピリジン化合物 | |
| CN117881679A (zh) | 新型化合物及其应用 | |
| JP7815147B2 (ja) | 新規イミダゾピラジン誘導体 | |
| CN118632842A (zh) | 两性离子抗细菌化合物 | |
| WO2022049272A1 (en) | Novel heterocyclic antibiotics | |
| CN115485279A (zh) | 抗菌8-苯基氨基-3-(吡唑-4-基)咪唑并[1,2-a]吡嗪衍生物 | |
| CN108779123A (zh) | 稠合四环化合物、其组合物和用途 | |
| HK40110645A (zh) | 两性离子抗细菌化合物 | |
| WO2017046606A1 (en) | Antibacterial compounds | |
| CN116829546A (zh) | 新型杂芳基取代的咪唑衍生物 | |
| WO2017046603A1 (en) | Antibacterial compounds and new uses thereof | |
| CN117999261A (zh) | 新化合物以及它们在治疗细菌感染中的用途 | |
| CN113087724B (zh) | 异噻唑并嘧啶酮类化合物，包含其的药物组合物及其用途 | |
| US20250346600A1 (en) | Tricyclic derivatives and related uses | |
| HK40107822A (zh) | 新化合物以及它们在治疗细菌感染中的用途 | |
| AU2017218556A1 (en) | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds | |
| HK40079569A (en) | Antibacterial 8-phenylamino-3-(pyrazol-4-yl)imidazo[1,2-a]pyrazine derivatives | |
| TW202545940A (zh) | 三環化合物、其製備方法及治療用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40110645 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |